Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser

Manufacturer
SOHM, Inc
Effective date
2023-04-30
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:48:57

Label at a glance#

ProductSodium Sulfacetamide 10 % and Sulfur 5 % Cleanser
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure16 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For Topical use only

Not for Ophthalmic use

Rx Only

DESCRIPTION:

DESCRIPTION SECTION

Sulfacetamide Sodium is a sulfonamide with antibacterial activity while Sulfur acts as a keratolytic agent. Chemically Sulfacetamide Sodium is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

structurestructure

Each gram of Sodium Sulfacetamide 10% and Sulfur 5% Cleanser contains 100 mg of Sodium Sulfacetamide and 50 mg of sulfur in a formulation containing: Aloe Vera Leaf, Butylated Hydroxytoluene, Camellia 0leifera Leaf, Cetyl Alcohol, Disodium Oleamido Monoethanolamine Sulfosuccinate, Edetate Disodium, Glycerin, Glyceryl Monostearate, Magnesium Aluminum Silicate, Methylpara­ben, Peg-100 Stearate, Propylparaben, Sodium Cocoyl Isethionate, Sodium Methyl Cocoyl Taurate, Sodium Thiosulfate, Stearyl Alcohol, Water, Xanthan Gum

CLINICAL PHARMACOLOGY SECTION

CLINICAL PHARMACOLOGY:

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sulfacetamide sodium is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is not known, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS & USAGE SECTION

INDICATIONS: Sulfacetamide Sodium and Sulfur Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS SECTION

CONTRAINDICATIONS: Sulfacetamide Sodium and Sulfur Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sulfacetamide Sodium and Sulfur  Cleanser is not to be used by patients with kidney disease.

WARNINGS SECTION

WARNINGS:

Although rare, sensitivity to Sulfacetaminde Sodium may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

SPL UNCLASSIFIED SECTION

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children. Keep container tightly closed.

PRECAUTIONS:

PRECAUTIONS SECTION

GENERAL PRECAUTIONS SECTION

General -If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but Sulfacetamide Sodium and Sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

INFORMATION FOR PATIENTS SECTION

Information for patients - Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Carcinogenesis, Mutagenesis and Impairment of Fertility - Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY SECTION

Pregnancy: Category C - Animal reproduction studies have not been conducted with Sulfacetamide Sodium and Sulfur lotion. It is also not known whether Sulfacetamide Sodium and Sulfur cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sulfacetamide Sodium and Sulfur cleanser should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS SECTION

Nursing Mothers - It is not known whether sulfacetamide sodium is excreted in the human milk following topical use of Sulfacetamide Sodium and Sulfur lotion. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sulfacetamide Sodium and Sulfur cleanser is administered to a nursing woman.

PEDIATRIC USE SECTION

Pediatric Use - Safety and effectiveness in children under the age of 12 have not been established.

ADVERSE REACTIONS SECTION

ADVERSE REACTIONS: Although rare, Sulfacetamide Sodium may cause local irritation.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: Use once daily or as directed by your physician. Wet skin. Apply in a film to entire face, avoiding contact with eyes or mucous membranes. Wait 10 minutes or until dry. Rinse thoroughly with water and pat dry.

HOW SUPPLIED SECTION

HOW SUPPLIED:

Sulfacetamide Sodium 10% and Sulfur 5% cleanser is supplied in
6 oz (170 g) bottle NDC #50405-850-01
12 oz (340 g) bottle NDC #50405-850-02

STORAGE AND HANDLING SECTION

Store at 20°-25°C (68°-77°F), excursions permitted between 15°-30°C (59°-86°F). Brief exposure to temperatures up to 40° (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C(77°F); however such exposure should be minimized. Protect from freezing.

SPL UNCLASSIFIED SECTION

Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

SPL UNCLASSIFIED SECTION

Rx Only

Manufactured for: SOHM, Inc. 2501 Commercial St., San Diego, CA 92113 USA

For any product questions or concerns please call: 800-284-1524
Rev. 04-2023

PRINCIPAL DISPLAY PANEL - 170 g Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50405-850-01

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser

Rx Only

6 oz (170 g)

label-170glabel-170g

PRINCIPAL DISPLAY PANEL - 340g Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50405-850-02

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser

Rx Only

12 oz (340 g)

label-340glabel-340g

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapPSN1
999613sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid SoapSCD1
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapSY1
999613sulfacetamide sodium 10 % / sulfur 5 % Topical CleanserSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50405-850-01Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser170 g in 1 BOTTLELIQUID1701
50405-850-02Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser340 g in 1 BOTTLELIQUID3401

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50405-850SODIUM SULFACETAMIDE 10 % AND SULFUR 5 % CLEANSER (SODIUM SULFACETAMIDE AND SULFUR) LIQUID [SOHM, INC]1Current NDC, 2 package rows20230504_dc4f3e25-a39d-4965-80e8-4fe2361a67d0.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50405-85050405-850-01, 50405-850-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Sulfacetamide 10 % and Sulfur 5 % CleanserSODIUM SULFACETAMIDE AND SULFURSOHM, Incdc4f3e25-a39d-4965-80e8-4fe2361a67d02023-04-30Warnings, Adverse reactionsExact identifier
ndc (package): 50405-850-02
ndc (package): 50405-850-01
ndc (product): 50405-850
ndc11 (package): 50405085002
ndc11 (package): 50405085001
spl id: 33c53704-fdee-4209-ac08-24ab0e8ebfd5
spl set id: dc4f3e25-a39d-4965-80e8-4fe2361a67d0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.